Cargando…
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson'd Disease: Final 12-Month, Open-Label Results
Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatment and linked to pulsatile dopaminergic stimulation. l-dopa-carbidopa intestinal gel (LCIG) is delivered continuously by percutaneous endoscopic gastrojejunostomy tube (PEG-J), which reduces l-dop...
Autores principales: | Fernandez, Hubert H, Standaert, David G, Hauser, Robert A, Lang, Anthony E, Fung, Victor SC, Klostermann, Fabian, Lew, Mark F, Odin, Per, Steiger, Malcolm, Yakupov, Eduard Z, Chouinard, Sylvain, Suchowersky, Oksana, Dubow, Jordan, Hall, Coleen M, Chatamra, Krai, Robieson, Weining Z, Benesh, Janet A, Espay, Alberto J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674978/ https://www.ncbi.nlm.nih.gov/pubmed/25545465 http://dx.doi.org/10.1002/mds.26123 |
Ejemplares similares
-
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson’s disease
por: Fernandez, Hubert H, et al.
Publicado: (2016) -
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics
por: Standaert, David G., et al.
Publicado: (2018) -
Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
por: Lang, Anthony E., et al.
Publicado: (2015) -
Reply to letter: Suicide in Parkinson's disease patients treated with levodopa‐carbidopa Intestinal Gel
por: Fernandez, Hubert H., et al.
Publicado: (2015) -
Effect of levodopa‐carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
por: Antonini, Angelo, et al.
Publicado: (2016)